Skip to main content
Press release November 12, 2026

Moleculin Secures Australian Patent for Annamycin Formulation Technology

Moleculin Biotech, Inc. (MBRX)

5300 Memorial Drive, Suite 950 Houston, TX, 77007 info@moleculin.com (713) 300-5160 Sign Up For Alerts Contact Us: info@moleculin.com Copyright © 2026 Moleculin. All Rights Reserved Privacy Policy Disclaimer 5300 Memorial Drive, Suite 950 |Houston, TX, 77007 info@moleculin.com (713) 300-5160 Sign Up For Alerts Contact Us: info@moleculin.com Copyright © 2026 Moleculin, Inc. All Rights Reserved Privacy Policy Disclaimer
View original release